[Ip-health] KEI notes on USPTO roundtable on genetic diagnostic testing

Krista L. Cox krista.cox at keionline.org
Mon Jan 14 09:45:40 PST 2013


On Thursday, 10 January 2013, USPTO held a roundtable on genetic diagnostic
testing. This roundtable followed up on the public hearing hosted by USPTO
nearly a year ago (and the written comments submitted). The purpose of the
public hearings last year was so that USPTO could gather information and
viewpoints in advance of the report it was directed to write at the behest
of Congress in the America Invents Act. Congress, in Section 27 of the AIA,
tasked USPTO to evaluate the lack of availability of secondary,
confirmatory testing and come up with recommendations in relation to
patenting and licensing practices in the context of genetic diagnostic
testing, specifically with regard to secondary or confirmatory testing. The
report was widely expected to be released in June 2012, but as Deputy
Teresa Rea noted at the opening of the roundtable, further review and
analysis was deemed necessary in order to "produce the best study possible."

Notes from the roundtable are available here: http://keionline.org/node/1638


-- 
Krista L. Cox
Staff Attorney
Knowledge Ecology International
www.keionline.org
(202) 332-2670



More information about the Ip-health mailing list